The effect of "Haldi" tampons in diabetic women.

A controlled clinical trial of Bruhtyadi tampons in Diabetes Mellitus associated vaginitis.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/11/029106

Enrollment

120

Registered

2020-11-13

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N761- Subacute and chronic vaginitis

Interventions

Intervention1: Bruhatyadi tampons: Bruhatyadi tampons will be placed in vagina once daily for 6 hrs for 10 days in DM associated vaginitis Control Intervention1: Betadine pessary: Betadine pessary wi

Eligibility

Inclusion criteria

Inclusion criteria: women of age 20 to 65 yrs with DM with vaginitis married women with known case of diabetes mellitus with vaginitis all cases of vaginitis with or without itching

Exclusion criteria

Exclusion criteria: Unmarried girls age below 20 yrs and above 65 yrs CA Cervix and Vagina Cases of HIV and HBV All cases of STDs menstrual period pregnant women

Design outcomes

Primary

Measure	Time frame
vaginal abnormal discharge vaginal itching vaginal burning pap smear vaginal smear Timepoint: Day 1 and day 10	—

Secondary

Measure	Time frame
vaginal pHTimepoint: Day 1 and day 10	—

Countries

India

Contacts

Public ContactDr Subhash Marlewar

R A Podar Medical College(Ayu,)

drsubhashmarlewar@gmail.com022-24934214

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026